Treatment for Unretractable Nausea
For unretractable nausea, a stepwise approach starting with dopamine receptor antagonists (metoclopramide, prochlorperazine, or haloperidol) as first-line treatment, followed by adding 5-HT3 antagonists (ondansetron), corticosteroids, and other adjunctive medications for persistent symptoms is recommended. 1, 2
First-Line Treatment Options
Begin with dopamine receptor antagonists as the initial treatment for persistent nausea 2:
Administer medications on a scheduled basis rather than as-needed for persistent nausea to maintain therapeutic levels 1, 4
Monitor for extrapyramidal side effects with dopamine antagonists, particularly in elderly patients 3
Second-Line and Adjunctive Treatments
If nausea persists despite first-line treatment, add a 5-HT3 receptor antagonist 1, 2:
Consider adding a corticosteroid for enhanced antiemetic effect 1, 4:
For anxiety-related or anticipatory nausea, add a benzodiazepine 1:
- Lorazepam: 0.5-2 mg PO/IV every 4-6 hours as needed 1
Cause-Specific Approaches
For medication-induced nausea (e.g., opioids, digoxin, antidepressants) 1, 2:
For gastric outlet obstruction or intra-abdominal tumor 1:
- Corticosteroids, proton pump inhibitor, metoclopramide, and consider stenting 1
For chemotherapy-induced nausea 1:
Management of Persistent Nausea
For nausea that remains uncontrolled despite above measures 1:
For patients unable to take oral medications 1:
- Use rectal, subcutaneous, or intravenous administration routes 1
Non-Pharmacological Approaches
Common Pitfalls and Caveats
Start with lower doses in elderly patients due to increased sensitivity to side effects 3
Monitor for sedation with antihistamines and benzodiazepines 3
Be aware that 5-HT3 antagonists can cause constipation, which may worsen symptoms 3
Metoclopramide carries risk of extrapyramidal side effects, especially at higher doses 4
Avoid abrupt discontinuation of benzodiazepines 3
Recognize that in clinical trials, placebo often resulted in significant improvement in nausea, suggesting that supportive care (IV fluids, rest) may be sufficient for many patients 7